全球自然杀手细胞治疗市场研究报告-产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

全球自然杀手细胞治疗市场规模预计将从 2024 年的 37.7 亿美元增长到 2033 年的 112.1 亿美元，在 2026 年至 2033 年的预测期内呈现 12.87% 的强劲年复合成长率(CAGR)。

随着人们越来越认识到 NK 细胞在癌症免疫治疗中的作用，自然杀手 (NK) 细胞治疗市场有望大幅成长。随着研究人员不断发现 NK 细胞在靶向和消除肿瘤细胞方面的潜力，对基于 NK 细胞的疗法的需求正在激增。细胞疗法的创新，包括工程化 NK 细胞和联合疗法的开发，正在增强这些治疗的有效性，使其对医疗保健提供者和患者更具吸引力。

此外，对个人化医疗的日益重视正在影响 NK 细胞治疗市场。随着医疗保健提供者寻求根据个别患者情况量身定制治疗方案，客製化 NK 细胞疗法的需求正在上升。这一趋势在血液系统恶性肿瘤和实体肿瘤的背景下尤其重要，个人化的治疗方法可以改善治疗结果并减少不良影响。

此外，对免疫疗法研发的日益关注正在促进 NK 细胞治疗市场的创新。生物製药公司、研究机构和临床中心之间的合作正在推动 NK 细胞技术和治疗方法的进步，确保新产品满足癌症患者不断变化的需求。医疗专业人员和患者对 NK 细胞疗法潜在益处的认识不断提高，这也促进了市场扩张。总之，自然杀手细胞治疗市场将实现强劲成长，其特点是技术进步、注重个人化治疗方法以及致力于改善癌症治疗。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

目录

第 1 章：前言

• 报告描述
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究流程
  • 市场研究方法

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：自然杀手细胞治疗产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业趋势
• 波特五力分析
• 市场吸引力分析
  • 治疗学市场吸引力分析
  • 市场吸引力分析：按应用
  • 最终用户的市场吸引力分析
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料製造商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球自然杀手细胞治疗市场分析：依治疗方式

• 治疗学概述
• 治疗学的历史和预测数据分析
• NK 细胞定向抗体
• NK 细胞疗法

第 6 章：全球自然杀手细胞治疗市场分析：按应用

• 概述：按应用
• 历史和预测数据分析：按应用
• 免疫增生性疾病
• 胃肠道疾病
• 癌症
• 其他

第 7 章：全球自然杀手细胞治疗市场分析：按最终用户

• 最终用户概览
• 最终用户的历史和预测数据分析
• 医院
• 研究中心和研究所
• 其他

第 8 章：全球自然杀手细胞治疗市场分析：按地区划分

• 区域展望
• 介绍
• 北美销售分析
  • 概述、历史和预测数据销售分析
  • 北美各细分市场销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测数据销售分析
  • 欧洲各细分市场销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测数据销售分析
  • 亚太地区分部销售分析
  • 亚太地区国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测数据销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测数据销售分析
  • 中东和非洲分部销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第 9 章：自然杀手细胞治疗公司的竞争格局

• 自然杀手细胞治疗市场竞争
• 伙伴关係/合作/协议
• 合併与收购
• 新产品发布
• 其他进展

第十章：公司简介

• 顶级公司市占率分析
• 市场集中度
• NKT Therapeutics Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Nkarta Therapeutics Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Nantkwest Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Innate Pharma SA
• 公司概况
• 公司收入
• 产品
• 最新动态
• Glycostem Therapeutics BV
• 公司概况
• 公司收入
• 产品
• 最新动态
• Fortress Biotech
• 公司概况
• 公司收入
• 产品
• 最新动态
• Fate Therapeutics
• 公司概况
• 公司收入
• 产品
• 最新动态
• Celgene Corporation
• 公司概况
• 公司收入
• 产品
• 最新动态
• Affimed NV
• 公司概况
• 公司收入
• 产品
• 最新动态
• Ziopharm Oncology Inc
• 公司概况
• 公司收入
• 产品
• 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Global Natural Killer Cells Therapeutics Market size is anticipated to grow from USD 3.77 Billion in 2024 to USD 11.21 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 12.87% during the forecast period of 2026 to 2033.

The natural killer (NK) cells therapeutics market is poised for significant growth, driven by the increasing recognition of the role of NK cells in cancer immunotherapy. As researchers continue to uncover the potential of NK cells in targeting and eliminating tumor cells, the demand for NK cell-based therapies is surging. Innovations in cell therapy, including the development of engineered NK cells and combination therapies, are enhancing the effectiveness of these treatments, making them more appealing to healthcare providers and patients.

Moreover, the growing emphasis on personalized medicine is influencing the NK cells therapeutics market. As healthcare providers seek to tailor treatments to individual patient profiles, the demand for customized NK cell therapies is rising. This trend is particularly relevant in the context of hematological malignancies and solid tumors, where personalized approaches can improve treatment outcomes and reduce adverse effects.

Furthermore, the increasing focus on research and development in immunotherapy is fostering innovation in the NK cells therapeutics market. Collaborations between bi opharmaceutical companies, research institutions, and clinical centers are driving advancements in NK cell technologies and treatment methodologies, ensuring that new products meet the evolving needs of cancer patients. The growing awareness of the potential benefits of NK cell therapies among healthcare professionals and patients is also contributing to market expansion. In summary, the natural killer cells therapeutics market is set for robust growth, characterized by technological advancements, a focus on personalized treatment approaches, and a commitment to improving cancer care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Therapeutics

• NK Cell Directed Antibodies
• NK Cell Therapies

By Application

• Immunoproliferative Disorders
• Gastrointestinal Diseases
• Cancer
• Other

By End User

• Hospitals
• Research Centers & Institutes
• Other
• COMPANIES PROFILED
• NKT Therapeutics Inc.
• Nkarta Therapeutics Inc.
• Nantkwest Inc.
• Innate Pharma S.A.
• Glycostem Therapeutics BV
• Fortress Biotech
• Fate Therapeutics
• Celgene Corporation
• Affimed N.V.
• Ziopharm Oncology Inc.
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. NATURAL KILLER CELLS THERAPEUTICS INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Therapeutics
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End User
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY THERAPEUTICS

• 5.1. Overview By Therapeutics
• 5.2. Historical and Forecast Data Analysis By Therapeutics
• 5.3. NK Cell Directed Antibodies Historic and Forecast Sales By Regions
• 5.4. NK Cell Therapies Historic and Forecast Sales By Regions

6. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Immunoproliferative Disorders Historic and Forecast Sales By Regions
• 6.4. Gastrointestinal Diseases Historic and Forecast Sales By Regions
• 6.5. Cancer Historic and Forecast Sales By Regions
• 6.6. Other Historic and Forecast Sales By Regions

7. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY END USER

• 7.1. Overview By End User
• 7.2. Historical and Forecast Data Analysis By End User
• 7.3. Hospitals Historic and Forecast Sales By Regions
• 7.4. Research Centers & Institutes Historic and Forecast Sales By Regions
• 7.5. Other Historic and Forecast Sales By Regions

8. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE NATURAL KILLER CELLS THERAPEUTICS COMPANIES

• 9.1. Natural Killer Cells Therapeutics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF NATURAL KILLER CELLS THERAPEUTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. NKT Therapeutics Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Nkarta Therapeutics Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Nantkwest Inc.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Innate Pharma S.A.
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Glycostem Therapeutics BV
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Fortress Biotech
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Fate Therapeutics
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Celgene Corporation
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Affimed N.V.
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Ziopharm Oncology Inc
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Therapeutics (USD MN)
• NK Cell Directed Antibodies Market Sales By Geography (USD MN)
• NK Cell Therapies Market Sales By Geography (USD MN)
• Analysis By Application (USD MN)
• Immunoproliferative Disorders Market Sales By Geography (USD MN)
• Gastrointestinal Diseases Market Sales By Geography (USD MN)
• Cancer Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Analysis By End User (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Research Centers & Institutes Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Global Natural Killer Cells Therapeutics Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Natural Killer Cells Therapeutics Report
• Market Research Process
• Market Research Methodology
• Global Natural Killer Cells Therapeutics Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Therapeutics
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By End User
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Therapeutics (USD MN)
• NK Cell Directed Antibodies Market Sales By Geography (USD MN)
• NK Cell Therapies Market Sales By Geography (USD MN)
• Global Market Analysis By Application (USD MN)
• Immunoproliferative Disorders Market Sales By Geography (USD MN)
• Gastrointestinal Diseases Market Sales By Geography (USD MN)
• Cancer Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Global Market Analysis By End User (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Research Centers & Institutes Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.